With a self-funded model and a focus on high-unmet-need areas in neuroscience, Alkermes plc (NASDAQ:ALKS) continues to ...

In June 2025, the FDA approved KEYTRUDA for perioperative use in adults with resectable, locally advanced head and neck ...

United Therapeutics Corporation (NASDAQ:UTHR) is among the most undervalued stocks to invest in. It is a biotechnology ...

AstraZeneca PLC (NASDAQ:AZN), a global biopharmaceutical company headquartered in Cambridge, UK, operates in over 130 ...

In February 2025, Biogen Inc. (NASDAQ:BIIB) formed a partnership with Stoke Therapeutics to develop zorevunersen for Dravet ...

Johnson & Johnson (NYSE:JNJ) is a global healthcare leader with a diverse portfolio across pharmaceuticals, medical devices, ...

Although dividend growth continued to slow during the second quarter, there are some positive signs for what may come next.

He stated that the market deserves the benefit of the doubt, as what got us here is the performance of growth sectors like ...

The US has recently reversed a ban on Nvidia that restricted them from sending its export control-compliant chip known as the ...

We recently published Jim Cramer Discusses These 10 Stocks & AI-Led Disinflation. MP Materials Corp. (NYSE:MP) is one of the ...

In its earnings release, Elevance Health, Inc. (NYSE:ELV) said net income during the period dropped by 24.2 percent to $1.744 ...